Related Experiment Video
Updated: Apr 13, 2026
Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
Published on: January 15, 2018
Lipid-based polymeric biomaterial-mediated ex vivo natural killer cell surface engineering
Jaewon Park1, Kyung Mu Noh1, Kyobum Kim1
1Department of Chemical & Biochemical Engineering, Dongguk University, Seoul 04620, Republic of Korea. kyobum.kim@dongguk.edu.
Abstract:
Natural killer (NK) cell-based immunotherapy has gained significant attention due to its ability to selectively recognize and eliminate cancer cells through immunological synapse formation while sparing normal cells. However, the therapeutic efficacy of NK cells against solid tumors remains limited, primarily due to insufficient tumor-specific targeting ligands. Although chimeric antigen receptor (CAR)-engineered NK cell therapy has been developed to address this challenge, its clinical translation is hindered by challenges like high cost, low transfection efficiency, and concerns associated with genetic modification. As an alternative, biomaterial-based NK cell surface engineering has emerged as a promising strategy to enhance tumor-targeting capabilities, without altering the intrinsic properties of NK cells. In particular, lipid-based polymeric biomaterial platforms enable efficient ligand-receptor interactions, thereby enhancing NK cell-mediated tumor recognition and cytotoxicity. This review highlights recent advances in the lipid-based NK cell surface engineering platform, discussing its advantages over genetic modifications and its potential to improve the efficacy of NK cell-based cancer immunotherapy.
Insights
Biomaterial engineering enhances natural killer (NK) cell immunotherapy for solid tumors. Lipid-based platforms improve NK cell targeting and cancer cell killing without genetic modification.
Area of Science:
- Immunology
- Biomaterials Science
- Cancer Therapy
Background:
- Natural killer (NK) cells offer targeted cancer cell elimination via immunological synapses.
- Therapeutic efficacy of NK cells against solid tumors is limited by poor tumor targeting.
- Current chimeric antigen receptor (CAR)-engineered NK cell therapy faces challenges like high cost and genetic modification concerns.
Purpose of the Study:
- To review advances in biomaterial-based NK cell surface engineering for cancer immunotherapy.
- To highlight lipid-based platforms as an alternative to genetic modification for enhancing NK cell function.
- To discuss the potential of surface-engineered NK cells in improving cancer treatment efficacy.
Main Methods:
- Review of recent literature on NK cell surface engineering using biomaterials.
- Focus on lipid-based polymeric platforms for ligand-receptor interactions.
- Comparison of biomaterial-based strategies with genetic modification approaches.
Main Results:
- Biomaterial-based NK cell surface engineering enhances tumor recognition and cytotoxicity.
- Lipid-based platforms facilitate efficient ligand-receptor interactions for improved targeting.
- Surface engineering preserves the intrinsic properties of NK cells.
Conclusions:
- Lipid-based biomaterial platforms represent a promising strategy for enhancing NK cell immunotherapy.
- This approach offers advantages over genetic modification, potentially overcoming clinical translation barriers.
- Surface-engineered NK cells hold significant potential for improving cancer treatment outcomes.
More Related Videos
11:02Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
